Browsing by Author LaRosa, John C.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 7 of 7
Issue DateTitleAuthor(s)Citation
2006Abstract 3357: Superiority of ApoB/ApoA1 Ratio for Predicting Cardiovascular Risk in Pooled Analyses of the Incremental Decrease in Endpoints through Aggressive Lipid-Lowering (IDEAL) and Treating to New Targets (TNT) TrialsBarter, Philip; Cater, Nilo B; Demicco, David A; Gaffney, Michael; Holme, Ingar; Kastelein, John J.P.; LaRosa, John C.; Olsson, Anders G; Pedersen, Terje R; Szarek, M; Central Clinical School: Heart Research InstituteAbstract 3357: Superiority of ApoB/ApoA1 Ratio for Predicting Cardiovascular Risk in Pooled Analyses of the Incremental Decrease in Endpoints through Aggressive Lipid-Lowering (IDEAL) and Treating to New Targets (TNT) Trials, Circulation (Baltimore), vol.114, N/A,pp II_713-II_714
2006Effect of intensive cholesterol lowering with atorvastatin in patients with previous coronary bypass surgery: a Treating to New Targets (TNT) substudyBarter, Philip; Kastelein, John J.P.; LaRosa, John C.; Shah, S.; Shepherd, James; Treating to New Targets, (TNT) Investigators; Waters, David D; Wenger, Nanette K.; Central Clinical School: Heart Research InstituteEffect of intensive cholesterol lowering with atorvastatin in patients with previous coronary bypass surgery: a Treating to New Targets (TNT) substudy, European Heart Journal (English Edition), vol.27, Suppl 1,pp 943-N/A
2005Intensive lipid lowering with atorvastatin in patients with stable coronary disease.Barter, Philip; et al, various; Fruchart, Jean-Charles; Gotto, Antonio M.; Greten, Heiner; Grundy, Scott M.; Kastelein, John J.P.; LaRosa, John C.; Shear, Charles; Shepherd, James; Waters, David D; Wenger, Nanette K.; Central Clinical School: MedicineIntensive lipid lowering with atorvastatin in patients with stable coronary disease., New England Journal of Medicine, vol.352,(14),2005,pp 1425-35
2013Levels and Changes of HDL Cholesterol and Apolipoprotein A-I in Relation to Risk of Cardiovascular Events Among Statin-Treated Patients: A Meta-AnalysisKirby, Adrienne; Sullivan, David; Amarenco, Pierre; Arsenault, Benoit J.; Boekholdt, S Matthijs; Colhoun, Helen; DeMicco, David A; et al, Various; Hovingh, G Kees; LaRosa, John C.; Mora, Samia; Pedersen, Terje R; Tonkin, Andrew; Welch, K; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreLevels and Changes of HDL Cholesterol and Apolipoprotein A-I in Relation to Risk of Cardiovascular Events Among Statin-Treated Patients: A Meta-Analysis, Circulation, vol.128, 14, 2013,pp 1504-1512
2008Lipids, Apolipoproteins, and Their Ratios in Relation to Cardiovascular Events With Statin TreatmentBarter, Philip; Boekholdt, S Matthijs; Cater, Nilo B; Deedwania, Prakash; DeMicco, David A; Gaffney, Michael; Grundy, Scott M; Holme, Ingar; Kastelein, John J.P.; LaRosa, John C.; Olsson, Anders G; Pedersen, Terje R; Szarek, Michael; van der Steeg, Wim A; Central Clinical School: Heart Research InstituteLipids, Apolipoproteins, and Their Ratios in Relation to Cardiovascular Events With Statin Treatment, Circulation, vol.117, 23, 2008,pp 3002-3009
2006On-treatment Levels of HDL-C and the Ratio of LDL-C/HDL-C as Predictors of Cardiovascular Events in the Treating to New Targets (TNT) StudyBarter, Philip; Bittner, V; Fruchart, Jean-Charles; Gotto, Antonio M.; Grundy, Scott M.; Kastelein, John J.P.; LaRosa, John C.; Central Clinical School: Heart Research InstituteOn-treatment Levels of HDL-C and the Ratio of LDL-C/HDL-C as Predictors of Cardiovascular Events in the Treating to New Targets (TNT) Study, Journal of the American College of Cardiology, vol.47, 4 Suppl A,pp 298A-N/A
2014Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trialsKeech, Anthony (Tony); Simes, Robert John; Amarenco, Pierre; Arsenault, Benoit J.; Boekholdt, S Matthijs; Colquhoun, David; DeMicco, David A; et al, Various; Hovingh, G Kees; LaRosa, John C.; Mora, Samia; Pedersen, Terje R; Waters, David; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreVery low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trials, Journal of the American College of Cardiology, vol.64, 5, 2014,pp 485-494